VanEck Associates’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $59K | Hold |
|
|||||
|
2020
Q4 | $65K | Hold |
|
|||||
|
2020
Q3 | $84K | Hold |
|
|||||
|
2020
Q2 | $54K | Sell |
|
|||||
|
2020
Q1 | $50K | Hold |
|
|||||
|
2019
Q4 | $65K | Buy |
|
|||||
|
2019
Q3 | $67K | Hold |
|
|||||
|
2019
Q2 | $61K | Sell |
|
|||||
|
2019
Q1 | $92K | Hold |
|
|||||
|
2018
Q4 | $60K | Buy |
|
|||||
|
2018
Q3 | $67K | Buy |
|
|||||
|
2018
Q2 | $61K | Buy |
|
|||||
|
2018
Q1 | $22K | Hold |
|
|||||
|
2017
Q4 | $20K | Sell |
|
|||||
|
2017
Q3 | $60K | Buy |
|
|||||
|
2017
Q2 | $45K | Sell |
|
|||||
|
2017
Q1 | $284K | Hold |
|
|||||
|
2016
Q4 | $310K | Buy |
|
|||||
|
2016
Q3 | $134K | Hold |
|
|||||
|
2016
Q2 | $105K | Buy |
|
|||||
|
2016
Q1 | $116K | Hold |
|
|||||
|
2015
Q4 | $121K | Buy |
|
|||||
|
2015
Q3 | $109K | Buy |
|
|||||
|
2015
Q2 | $130K | Buy |
|